SCHEMBL11889293

SCHEMBL11889293

Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ccncc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRAF P15056 10/20 0.76
LCK P06239 8/20 0.76
TEK Q02763 7/20 0.76
KDR P35968 12/20 0.67
RAF1 P04049 2/20 0.62
MAPK14 Q16539 2/20 0.47
CSF1R P07333 2/20 0.46
DDR1 Q08345 2/20 0.46
DDR2 Q16832 1/20 0.46
FLT1 P17948 7/20 0.41
CIT O14578 1/20 0.39
EGFR P00533 1/20 0.39
HLA-A P04439 1/20 0.39
RET P07949 1/20 0.39
PDGFRB P09619 1/20 0.39
KIT P10721 1/20 0.39
PDGFRA P16234 1/20 0.39
RPS6KB1 P23443 1/20 0.39
FLT4 P35916 1/20 0.39
FRK P42685 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11889282 0.87 BRAF (0.78) BRAFLCKTEKKDRRAF1
SCHEMBL11889124 0.87 BRAF (1.00) BRAFLCKTEKKDRRAF1
SCHEMBL22223986 0.80 BRAF (0.71) BRAFLCKTEKKDRRAF1
SCHEMBL2517955 0.80 BRAF (1.00) BRAFLCKTEKKDRRAF1
SCHEMBL11889285 0.80 BRAF (0.66) BRAFLCKTEKKDRRAF1
SCHEMBL15215289 0.79 BRAF (0.78) BRAFLCKTEKKDRRAF1
SCHEMBL30499048 0.77 BRAF (1.00) BRAFLCKTEKKDRRAF1
SCHEMBL18155155 0.77 BRAF (1.00) BRAFLCKTEKKDRRAF1
Hydrochloric Acid SCHEMBL19873385 0.77 BRAF (1.00) BRAFLCKTEKKDRRAF1
Hydrochloric Acid SCHEMBL19873386 0.77 BRAF (1.00) BRAFLCKTEKKDRRAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1976836-B9 NITROGEN-CONTAINING BICYCLIC HETEROARYL COMPOUNDS FOR THE TREATMENT OF RAF PROTEIN KINASE-MEDIATED DISEASES AMGEN INC (US) 2013-02-06 EP disclosed
EP-1976836-B1 NITROGEN-CONTAINING BICYCLIC HETEROARYL COMPOUNDS FOR THE TREATMENT OF RAF PROTEIN KINASE-MEDIATED DISEASES AMGEN INC (US) 2012-08-22 EP disclosed
EP-2481729-A1 Nintrogen-containing bicyclic heteroaryl compounds for the treatment of RAF protein kinase-mediated diseases Amgen Inc. (US) 2012-08-01 EP disclosed